Status:

COMPLETED

Strategies for Asymmetrical Triacetate Dialyzer Heparin-Free Effective Hemodialysis

Lead Sponsor:

Universitaire Ziekenhuizen KU Leuven

Collaborating Sponsors:

NIPRO

Conditions:

Hemodialysis Complication

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Not all dialysis patients tolerate heparin anticoagulation. Heparin should be avoided in patients at high risk of bleeding. Strategies include saline infusion, citrate-containing dialysate, regional c...

Detailed Description

Anticoagulation is one of the supporting pillars of chronic hemodialysis (HD). The optimal anticoagulant regimen provides full anticoagulation of the extracorporeal circuit with minimal systemic effec...

Eligibility Criteria

Inclusion

  • Patients age 18 years, or over. No maximum age is defined.
  • Providing signed and dated informed consent (ICF)
  • Maintenance dialysis (\> 3 months of hemodialysis)
  • 'Standard' dialysis regimen (three dialysis sessions / week, dialysis duration 4 hours)
  • Hemodynamic stability during 4 weeks preceding study period. Hemodynamic instability is defined as any episode of low blood pressure (asymptomatic or symptomatic requiring intervention (bolus fluid infusion, temporarily withholding or reducing ultrafiltration, preterm termination of dialysis session, resuscitation)
  • Hemoglobin 9 - 12 g/dl.

Exclusion

  • Any known medical disorder favoring either bleeding or clotting (e.g. atypical hemolytic uremic syndrome (aHUS), antiphospholipid syndrome, idiopathic thrombocytopenic purpura (ITP), paroxysmal nocturnal hemoglobinuria (PNH))
  • Treatment with a vitamin K antagonist
  • Treatment with any one of the NOACs (apixaban, rivaroxaban, edoxaban, dabigatran)
  • High risk of bleeding according to the criteria of Swartz (12).
  • Patients with a known allergic reaction to asymmetric triacetate
  • Pregnancy

Key Trial Info

Start Date :

January 6 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 5 2020

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04381234

Start Date

January 6 2018

End Date

May 5 2020

Last Update

May 21 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospitals Leuven

Leuven, Vlaams-Brabant, Belgium, 3000